[go: up one dir, main page]

PE8497A1 - Dihidrobenzofurano y compuestos relacionados utiles como agentes antiinflamatorios - Google Patents

Dihidrobenzofurano y compuestos relacionados utiles como agentes antiinflamatorios

Info

Publication number
PE8497A1
PE8497A1 PE1995274758A PE27475895A PE8497A1 PE 8497 A1 PE8497 A1 PE 8497A1 PE 1995274758 A PE1995274758 A PE 1995274758A PE 27475895 A PE27475895 A PE 27475895A PE 8497 A1 PE8497 A1 PE 8497A1
Authority
PE
Peru
Prior art keywords
substituted
cyclic
atoms
branched
carbon
Prior art date
Application number
PE1995274758A
Other languages
English (en)
Inventor
Michael Wiard Scherz
Randall Stryker Matthews
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of PE8497A1 publication Critical patent/PE8497A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

SE REFIERE A COMPUESTOS DE FORMULA (I), DONDE: X ES OXIGENO O AZUFRE DE PREFERENCIA OXIGENO; CADA Y ES INDEPENDIENTEMENTE HIDROGENO O ALCANILO LINEAL, RAMIFICADO O CICLICO NO SUSTITUIDO QUE TIENE UNO A TRES ATOMOS DE CARBONO APROXIMADAMENTE, DE PREFERENCIA METILO, ETILO O LAS DOS Y ESTAN ENLAZADAS PARA FORMAR UN ANILLO ALCANILO QUE TIENE DE TRES A SIETE ATOMOS DE CARBONO APROXIMADAMENTE; Z ES HIDROGENO, ALQUILO RAMIFICADO O CICLICO NO SUSTITUIDO O FENILO NO SUSTITUIDO O SUSTITUIDO DE ALCANILO DE TRES A DIEZ ATOMOS DE CARBONO; W ES ALQUILO O ARILO LINEAL, RAMIFICADO O CICLICO, SUSTITUIDOS O NO, SATURADO O MONO O DI-INSATURADO, CON ENLACES DOBLES EXCEPTO QUE NINGUN ATOMO DE CARBONO TERMINAL DE W ES PARTE DE UN ENLACE DOBLE, W TIENE DE UNO A QUINCE ATOMOS DE CARBONO APROXIMADAMENTE DISTINTOS A HIDROGENO. ESTOS COMPUESTOS SE CARACTERIZAN POR INHIBIR LA SINTESIS DE LEUCOTRIENOS REDUCIENDO LA ACUMULACION NEUTROFILA EN EL LUGAR DE LA INFLAMACION
PE1995274758A 1994-07-27 1995-07-26 Dihidrobenzofurano y compuestos relacionados utiles como agentes antiinflamatorios PE8497A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US28089294A 1994-07-27 1994-07-27

Publications (1)

Publication Number Publication Date
PE8497A1 true PE8497A1 (es) 1997-03-24

Family

ID=23075045

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1995274758A PE8497A1 (es) 1994-07-27 1995-07-26 Dihidrobenzofurano y compuestos relacionados utiles como agentes antiinflamatorios

Country Status (7)

Country Link
US (2) US5656661A (es)
KR (1) KR100248320B1 (es)
DE (1) DE69535697T2 (es)
MX (1) MX9700726A (es)
PE (1) PE8497A1 (es)
TW (1) TW304194B (es)
ZA (1) ZA956262B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4202250B2 (ja) 2001-07-25 2008-12-24 バイオマリン ファーマシューティカル インコーポレイテッド 血液脳関門輸送を調節するための組成物および方法
JP4560394B2 (ja) * 2004-12-13 2010-10-13 長州産業株式会社 薄膜形成用分子供給装置
EP3827747A1 (en) 2005-04-28 2021-06-02 Otsuka Pharmaceutical Co., Ltd. Pharma-informatics system
CN101594878A (zh) 2006-09-18 2009-12-02 雷普特药品公司 通过给予受体相关蛋白（rap）-缀合物对肝病症的治疗
DK3395372T3 (da) 2009-02-20 2022-04-19 Enhanx Biopharm Inc System til afgivelse af glutathion-baseret medikament
CN110075069A (zh) 2009-05-06 2019-08-02 实验室护肤股份有限公司 包含活性剂-磷酸钙颗粒复合物的皮肤递送组合物及其应用
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3551456A (en) * 1968-04-18 1970-12-29 Universal Oil Prod Co Acetyl derivatives of substituted chromans and coumarans
JPS6031829B2 (ja) * 1975-06-26 1985-07-24 ウェルファイド株式会社 アミノアルコ−ル誘導体の製造法
FR2370472A2 (fr) * 1976-11-10 1978-06-09 Continental Pharma Amino-alcool heterocyclique, son sel et son procede de preparation
FR2332010A1 (fr) * 1975-11-18 1977-06-17 Continental Pharma Amino-alcool heterocyclique, son sel et son procede de preparation
CH615031A5 (es) * 1976-04-30 1979-12-28 Gretag Ag
JPS6019305B2 (ja) * 1976-07-02 1985-05-15 ウェルファイド株式会社 ジヒドロベンゾフラン誘導体
JPS603305B2 (ja) * 1976-12-27 1985-01-26 エーザイ株式会社 ２，３―ジハイドロベンゾフラン誘導体
US4130666A (en) * 1977-05-16 1978-12-19 Riker Laboratories, Inc. Anti-inflammatory method
IT1093805B (it) * 1978-01-31 1985-07-26 Erba Carlo Spa Derivati del 2h-benzofuran-3-one e procedimento per la loro preparazione
EP0026593A1 (en) * 1979-09-15 1981-04-08 Pfizer Limited Bicyclic keto- and amino- acids, esters and amides and pharmaceutical compositions thereof
GR81257B (es) * 1982-12-04 1984-12-11 Lilly Industries Ltd
EP0117675B1 (en) * 1983-02-19 1986-07-23 Beecham Group Plc Benzofuran and benzothiophene-carboxylic-acid derivatives
FI842738A7 (fi) * 1983-07-14 1985-01-15 Syntex Inc Aroyylibentsofuraani- ja bentsotiofeenietikka- ja propionihapot.
US4613611A (en) * 1983-10-14 1986-09-23 American Cyanamid Company Method of treating diabetes mellitus using arylglyoxals
AU4261285A (en) * 1984-06-01 1985-12-05 Tokyo Tanabe Company Limited 1-propanone derivatives
US4708966A (en) * 1986-06-27 1987-11-24 The Procter & Gamble Company Novel anti-inflammatory agents, pharmaceutical compositions and methods for reducing inflammation
FR2613364B1 (fr) * 1987-04-01 1989-06-09 Adir Nouvelles amines tricycliques derivees du tetrahydro-5, 6, 7, 8 naphto (2, 3b) dihydro-2, 3 furanne, et du tetrahydro-6, 7, 8, 9 5h-benzocyclohepta (2, 3b) dihydro-2, 3 furanne, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
FR2613365B1 (fr) * 1987-04-01 1989-07-28 Adir Nouveaux derives de l'amino tetrahydro-5, 6, 7, 8 naphto (2, 3b) furanne, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
US4849428A (en) * 1987-11-23 1989-07-18 The Procter & Gamble Company Cyclic anti-inflammatory derivatives of di-tert-butylphenol compounds, compositions and use
US4982006A (en) * 1987-12-18 1991-01-01 Norwich Eaton Pharmaceuticals, Inc. Process for the preparation of certain substituted aromatic compounds
IL88674A0 (en) * 1987-12-18 1989-07-31 Norwich Eaton Pharma Preparation of certain substituted aromatic compounds
JPH07121933B2 (ja) * 1988-03-28 1995-12-25 キッセイ薬品工業株式会社 ジヒドロベンゾフラノン誘導体
GB8906166D0 (en) * 1989-03-17 1989-05-04 Pfizer Ltd Therapeutic agents
JP2808460B2 (ja) * 1989-11-16 1998-10-08 大正製薬株式会社 イミダゾール誘導体
JPH03215485A (ja) * 1990-01-11 1991-09-20 Taisho Pharmaceut Co Ltd ベンゾチエニルイミダゾール誘導体
TW197435B (es) * 1990-11-22 1993-01-01 Takeda Pharm Industry Co Ltd
JPH06263733A (ja) * 1993-01-14 1994-09-20 Sankyo Co Ltd ベンゼン誘導体

Also Published As

Publication number Publication date
KR970704723A (ko) 1997-09-06
ZA956262B (en) 1996-02-29
TW304194B (es) 1997-05-01
US5656661A (en) 1997-08-12
KR100248320B1 (ko) 2000-04-01
DE69535697D1 (de) 2008-03-20
US5674891A (en) 1997-10-07
DE69535697T2 (de) 2009-09-03
MX9700726A (es) 1997-05-31

Similar Documents

Publication Publication Date Title
DK1485359T3 (da) Natriumkanalblokkere
ES2196630T3 (es) Isotiazolcarboxiamidas y su empleo para la proteccion de las plantas.
SE0300956L (sv) Stabilisatorblandningar
ES2097847T3 (es) Inhibidores de encefalinasa y eca con un radical carboxialquilo.
EA200300337A1 (ru) Полиарилкарбоксамиды, применимые в качестве агентов, снижающих содержание липидов
PT90623A (pt) Processo para a preparacao de n-heterociclil-4-guanilalquil-benzamidas uteis como inibidores de protease
SV1998000008A (es) Inhibisores de sulfamida-metaloproteasa. ref. ran 4070\114
ES2124219T3 (es) Agentes que proporcionan caracteristicas de deslizamiento.
EA200000098A1 (ru) 4-АМИНОПИРРОЛ(3,2-d)ПИРИМИДИНЫ В КАЧЕСТВЕ АНТАГОНИСТОВ РЕЦЕПТОРА НЕЙРОПЕПТИДА Y
ES2189476T3 (es) Odorizado de gases.
SE7813385L (sv) 15-deoxi-16-hydroxiprostaglandiner
DE60119964D1 (de) Kraftstoffzusammensetzung
EA200000804A1 (ru) Мета-азациклические соединения аминобензойной кислоты и их производные, являющиеся ингибиторами интегрина
PE8497A1 (es) Dihidrobenzofurano y compuestos relacionados utiles como agentes antiinflamatorios
EA200000910A1 (ru) Азабициклические лиганды рецепторов 5нт1
ATE226210T1 (de) Phospholipidanaloge verbindungen
EA200100517A1 (ru) Антагонисты 5ht1 для антидепрессантной терапии
NO20022977D0 (no) Substituerte homopiperidinylbenzimidazolanaloger som fundiske relaksanter
EA200000628A1 (ru) Ингибиторы металлопротеаз матрикса
BR9508436A (pt) Dihidro benzofurando e compostos correlacionados úteis como agentes anti-inflamatórios
ES479040A1 (es) Procedimiento para preparar cetoximinoeteres.
DK0745081T3 (da) Indan-2-mercaptoacetylamiddisulfidderivater, der er anvendelige som enkephalinase-inhibitorer
ES2158887T3 (es) Procedimiento para tratar la prostatitis cronica con 17 beta-n-terc-butilcarbamoil-4-aza-5 alfa-androst-1-en-ona.
EA200201023A1 (ru) Ингибитор натрий-водородного обмена типа 1(nhe-1)
EA200100065A1 (ru) Производные гидроксамовой кислоты как ингибиторы продуцирования cd23 человека и высвобождения tnf

Legal Events

Date Code Title Description
FA Abandonment or withdrawal